or Try an Advanced Search...
    Invalid date chosen. Displaying data for the latest date instead.

    Percutaneous Coronary Intervention Stocks List

    Symbol Grade Name % Change
    LLY B Eli Lilly and Company -0.95
    NSPR C InspireMD, Inc. 3.53
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Percutaneous Coronary Intervention stocks.

    Symbol Grade Name Weight
    IHE B iShares U.S. Pharmaceutical ETF 23.55
    OZEM D Roundhill GLP-1 & Weight Loss ETF 21.39
    MEDX B Horizon Kinetics Medical ETF 16.22
    THNR D Amplify Weight Loss Drug & Treatment ETF 15.58
    IYH C iShares U.S. Healthcare ETF 13.74
    View all Percutaneous Coronary Intervention ETFs...
    Compare ETFs
    Compare IHE to OZEM Compare OZEM to IYH Compare OZEM to MEDX

        Percutaneous Coronary Intervention Stocks Recent News

        Date Stock Title
        Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
        Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
        Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
        Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
        Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
        Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
        Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
        Jul 3 LLY Top 3 Health Care Stocks That May Crash This Quarter
        Jul 3 LLY Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
        Jul 3 LLY 5 Things to Know Before the Stock Market Opens
        Jul 3 LLY Eli Lilly Advances Alzheimer's Solutions With Kisunla Approval
        Jul 3 LLY Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
        Jul 3 LLY Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
        Jul 2 LLY Boeing, Tesla stock reaction, small-cap portfolio: Market Domination
        Jul 2 LLY Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease
        Jul 2 LLY Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
        Jul 2 LLY Alzheimer’s Disease Treatments: What to Know About New and Future Drugs
        Jul 2 LLY Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
        Jul 2 LLY Eli Lilly Gets FDA Approval for Alzheimer's Disease Drug
        Jul 2 LLY Biden, Sanders call for obesity drug makers to cut prices
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes
        Percutaneous Coronary Intervention

        Percutaneous Coronary Intervention (PCI) is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. It involves inserting a catheter into a blood vessel in the arm or leg and guiding it to the narrowed or blocked coronary artery. A balloon is then inflated to widen the artery and a stent is inserted to keep it open. PCI can improve blood flow to the heart and reduce the risk of a heart attack.

        Browse All Tags